The Diabetic Retinopathy Screening, Prevention and Control Program

Recruiting now

Conditions studied: Diabetic Retinopathy

In brief

The greatest harm of diabetes is various acute and chronic complications, especially diabetic retinopathy(DR), leading to extremely high rates of disability and blindness. Early screening, early diagnosis, and early treatment are the keys to maintaining vision in patients with DR. However, compared with the high prevalence of diabetes in China, the DR screening ability is relatively inadequate. To change this situation, deep learning(DL), a form of artificial intelligence (AI), might be a potential effective method to solve this dilemma.

Key facts

Study ID
NCT04240652
Run by
Shanghai Jiao Tong University School of Medicine
People needed
500000
Starts
2018-06-05
Expected to finish
2040-06-05
Last updated by the study team
2020-02-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.